Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine

Achieving improvements in survival and reducing relapse remains a challenge in acute myelogenous leukemia (AML) patients. This study evaluated the in vitro efficacy of the active form of novel agent sapacitabine, CNDAC, compared to current chemotherapeutic drugs Ara-C and mitoxantrone using two AML...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Jagan, Sucheta, Paganessi, Laura A., Frank, Robin R., Venugopal, Parameswaran, Larson, Melissa, Christopherson, Kent W.
格式: Artigo
語言:Inglês
出版: Hindawi Publishing Corporation 2012
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3461608/
https://ncbi.nlm.nih.gov/pubmed/23049558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/727683
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍